Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
HIVAcquired Immunodeficiency SyndromeInfluenza
Interventions
DRUG

Seasonal trivalent inactivated influenza vaccine (Vaxigrip®)

Administer seasonal trivalent inactivated influenza vaccine (Vaxigrip®) and collect blood specimens at 0, 1, 3, 7, 14, 28 and 100 days following vaccination.

Trial Locations (1)

Unknown

Makere University- Johns Hopkins University Research Collaboration, at the Mulago National Referral Hospital, Kampala

All Listed Sponsors
collaborator

Makerere University

OTHER

lead

Emory University

OTHER

NCT01916759 - Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda | Biotech Hunter | Biotech Hunter